These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
940 related articles for article (PubMed ID: 7560608)
1. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Hohnloser SH; van de Loo A; Baedeker F J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608 [TBL] [Abstract][Full Text] [Related]
2. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study]. Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720 [TBL] [Abstract][Full Text] [Related]
3. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine]. Trappe HJ; Pfitzner P Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638 [TBL] [Abstract][Full Text] [Related]
4. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G; Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102 [TBL] [Abstract][Full Text] [Related]
5. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison]. Kalusche D; Stockinger J; Betz P; Roskamm H Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939 [TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Joseph AP; Ward MR Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228 [TBL] [Abstract][Full Text] [Related]
7. Amiodarone versus sotalol for atrial fibrillation. Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD; N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201 [TBL] [Abstract][Full Text] [Related]
8. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924 [TBL] [Abstract][Full Text] [Related]
9. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Frick M; Darpö B; Ostergren J; Rosenqvist M Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation: rate control often better than rhythm control. Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984 [TBL] [Abstract][Full Text] [Related]
11. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter]. Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study. Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088 [TBL] [Abstract][Full Text] [Related]
14. [Cardioversion in atrial fibrillation. Results and complications in 1,152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians]. Tebbe U; Carlsson J; Seidl K; Jansen W; Schuster HP; Elsner M; Neuhaus KL; Praetorius F Med Klin (Munich); 1995 Dec; 90(12):681-7. PubMed ID: 8583983 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium]. Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. Kerin NZ; Faitel K; Naini M Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696 [TBL] [Abstract][Full Text] [Related]
17. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation]. Zehender M; Meinertz T; Just H Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938 [TBL] [Abstract][Full Text] [Related]
18. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T; Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and proarrhythmia of oral sotalol in pediatric patients. Pfammatter JP; Paul T; Lehmann C; Kallfelz HC J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592 [TBL] [Abstract][Full Text] [Related]
20. [A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation]. Carunchio A; Fera MS; Mazza A; Burattini M; Greco G; Galati A; Ceci V G Ital Cardiol; 1995 Jan; 25(1):51-68. PubMed ID: 7642012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]